01 September 1998
Increased frequency of defected CYP2D6 gene alleles among children with leukemia in comparison to children with infectious diseases and atopic allergy
Elżbieta Zielińska, Henryk W. Witas, Jerzy BodalskiMed Sci Monit 1998; 4(5): BR756-764 :: ID: 501961
Abstract
The aim of this study was to evaluate the frequency of CYP2D6 gene mutations in Polish children as well as to determine the significance of genotypes encoding poor metabolizer phenotypes in chronic diseases such as atopic allergy and lympho-myeloproliferative diseases. Out of 172 children of which 94 had been treated for acute infectious diseases, 57 presented with atopic allergy and 21 with lympho-myeloproliferative diseases. We isolated DNA from peripheral blood. We identified by means of the allele-specific amplification assay (ASA) followed by analysis of restriction fragment length polymorphism the presence of A 2367 deletion in exon 5 (allele D6-A) and G1934→A transition replacing the junction between intron 3 and exon 4 (allele D6-B), in the CYP2D6 gene. This method allows for the detection of genotypes encoding cytochrome P4502D6 (presence of allele wt) and identifies poor metabolizers which are homozygous or heterozygous for defective D6-A and D6-B alleles. In 5.0% of the studied children we noted genotypes with two defective alleles, which reflects the occurrence of poor metabolizers in other parts of Europe. The frequency of mutations and distribution of genotypes in children with allergies is comparable to results obtained from the control group. However, in children with lymphoproliferative diseases and positive family history of neoplasms, mutated alleles appear statistically significantly more frequently (p< 0.0003). In these children genotypes encoding metabolic defects were identified twice as frequently. The identification of CYP2D6 gene mutations may be useful in the determination of risk factors such as the genetic predisposition to lympho-myeloproliferative diseases.
Keywords: mono-oxygenase cytochrome P450, genotype CYP2D6, children, Allergy, Leukemia
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952